Filing Details
- Accession Number:
- 0001127602-18-020924
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-14 16:45:43
- Reporting Period:
- 2018-06-12
- Accepted Time:
- 2018-06-14 16:45:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1667779 | P Michael Spears | C/O Insulet Corporation 600 Technology Park Drive, Suite 200 Billerica MA 01821 | Svp, Qa And Ra | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-06-12 | 1,075 | $29.87 | 36,746 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-06-12 | 1,075 | $100.00 | 35,671 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-06-13 | 6,421 | $29.87 | 42,092 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-06-13 | 6,421 | $100.00 | 35,671 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-06-12 | 1,075 | $0.00 | 1,075 | $29.87 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-06-13 | 6,421 | $0.00 | 6,421 | $29.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
19,771 | 2025-07-27 | No | 4 | M | Direct | |
13,350 | 2025-07-27 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018, as amended on May 17, 2018.
- Includes 4,328 restricted stock units granted on February 22, 2017, which vest as to one-half of the total units on February 22, 2019 and one-half of the total units on February 22, 2020; 7,477 restricted stock units granted on July 27, 2015, which vest on July 27, 2018; 3,418 restricted stock units granted on February 24, 2016, which vest on February 24, 2019; 5,982 performance share units granted on February 24, 2016, which vest on February 24, 2019; and 4,027 restricted stock units granted on February 14, 2018, which vest as to one-third of the total units on February 14, 2019, one-third of the total units on February 14, 2020 and one-third of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
- This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.